Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

DOI Web Site Web Site 1 Citations

Journal

  • The Lancet

    The Lancet 401 (10373), 269-280, 2023-01

    Elsevier BV

Citations (1)*help

See more

Report a problem

Back to top